申请人:Hutchison Medipharma Limited
公开号:US20210363115A2
公开(公告)日:2021-11-25
The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, and/or solvates, racemic mixtures, enantiomers, diasteromers, and tautomers thereof, wherein A, R
1
, R
2
, R
3
, R
3
′, R
4
, R
4
′, R
5
, R
6
, R
7
, R
8
, m, and n are as defined in the detailed description of the invention.